TELA Bio, Inc.
TELA
$0.89
-$0.0662-6.92%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 11.22% | 17.68% | -122.58% | 56.08% | -17.64% |
| Total Depreciation and Amortization | 1.14% | 5.62% | 6.41% | 45.34% | -26.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 32.31% | 19.12% | 127.02% | -423.95% | -0.56% |
| Change in Net Operating Assets | -43.01% | -918.89% | 102.84% | -2,806.42% | -105.52% |
| Cash from Operations | 16.16% | 16.02% | 25.63% | -30.16% | -58.60% |
| Capital Expenditure | -116.39% | 59.20% | 1.64% | -48.29% | -52.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -92.68% | -- | -- |
| Cash from Investing | -55.74% | -282.09% | -98.57% | 2,533.16% | -44.03% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 36,582.91% | 1,850.00% | -98.44% | 1,376.92% | -65.79% |
| Repurchase of Common Stock | 42.11% | -72.73% | 96.65% | -8,100.00% | 20.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 43,683.67% | 2,060.00% | -108.93% | 154.55% | -69.01% |
| Foreign Exchange rate Adjustments | 196.81% | -1,466.67% | -126.09% | 228.57% | 142.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 484.65% | 13.64% | -11.07% | 14.47% | -58.66% |